Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary
R Gorlick, P Anderson, I Andrulis, C Arndt… - Clinical Cancer …, 2003 - AACR
Childhood osteogenic sarcoma (OS) is a rare bone cancer occurring primarily in
adolescents. The North American pediatric cooperative groups have performed a series of …
adolescents. The North American pediatric cooperative groups have performed a series of …
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Importance The clinical management ofBRCA1andBRCA2mutation carriers requires
accurate, prospective cancer risk estimates. Objectives To estimate age-specific risks of …
accurate, prospective cancer risk estimates. Objectives To estimate age-specific risks of …
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira… - Nature …, 2013 - nature.com
Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for∼ …
been identified as associated with susceptibility to breast cancer, and these account for∼ …
Risk of pancreatic cancer in breast cancer families from the breast cancer family registry
E Mocci, RL Milne, EY Méndez-Villamil… - … , biomarkers & prevention, 2013 - AACR
Background: Increased risk of pancreatic cancer has been reported in breast cancer families
carrying BRCA1 and BRCA2 mutations; however, pancreatic cancer risk in mutation …
carrying BRCA1 and BRCA2 mutations; however, pancreatic cancer risk in mutation …
[HTML][HTML] Breast-Cancer Risk in Families with Mutations in PALB2
AC Antoniou, S Casadei, T Heikkinen… - … England Journal of …, 2014 - Mass Medical Soc
Background Germline loss-of-function mutations in PALB2 are known to confer a
predisposition to breast cancer. However, the lifetime risk of breast cancer that is conferred …
predisposition to breast cancer. However, the lifetime risk of breast cancer that is conferred …
[HTML][HTML] MADR2 maps to 18q21 and encodes a TGFβ–regulated MAD–related protein that is functionally mutated in colorectal carcinoma
K Eppert, SW Scherer, H Ozcelik, R Pirone, P Hoodless… - Cell, 1996 - cell.com
The MAD–related (MADR) family of proteins are essential components in the signaling
pathways of serine/threonine kinase receptors for the transforming growth factor β (TGFβ) …
pathways of serine/threonine kinase receptors for the transforming growth factor β (TGFβ) …
[PDF][PDF] Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
N Mavaddat, K Michailidou, J Dennis, M Lush… - The American Journal of …, 2019 - cell.com
Stratification of women according to their risk of breast cancer based on polygenic risk
scores (PRSs) could improve screening and prevention strategies. Our aim was to develop …
scores (PRSs) could improve screening and prevention strategies. Our aim was to develop …
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
XR Yang, J Chang-Claude, EL Goode… - Journal of the …, 2011 - academic.oup.com
Background Previous studies have suggested that breast cancer risk factors are associated
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors …
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors …
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
Context Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry
deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2 …
deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2 …
[HTML][HTML] HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
KI Pritchard, LE Shepherd, FP O'Malley… - … England Journal of …, 2006 - Mass Medical Soc
Background Amplification of the human epidermal growth factor receptor type 2 (HER2, also
called HER2/neu) gene and overexpression of its product in breast-cancer cells may be …
called HER2/neu) gene and overexpression of its product in breast-cancer cells may be …